In vitro screening of NADPH oxidase inhibitors and in vivo effects of L-leucinethiol on experimental autoimmune encephalomyelitis-induced mice

Journal of the Neurological Sciences
Lakshmi Devi KandagaddalaOh-Seung Kwon

Abstract

Experimental autoimmune encephalomyelitis (EAE), a Th1 polarized demyelinating disease of the central nervous system, shares many pathological and clinical similarities with multiple sclerosis (MS). The objectives of this study were i) to evaluate the suppressive effects of L-leucinethiol (LeuSH), a metalloprotease inhibitor on EAE-induced mice and ii) to study the effects of LeuSH on matrix metalloproteinase-9 (MMP-9), NADPH oxidase and cytokines (IFN-γ, IL-5 and IL-10) in tissues and plasma of EAE mice as a measure of potential markers associated with EAE disease. C57BL/6 mice were immunized with myelin oligodendrocyte glycoprotein (MOG35-55) peptide in complete Freund's adjuvant to induce EAE. A significant difference was observed in body weights and clinical signs of LeuSH (8 mg/kg) administered EAE-induced mice compared to control mice. The findings of this study include alterations in the enzymatic expression of MMP-9, NADPH oxidase and cytokine levels in the brain, spinal cord, spleen, thymus and plasma of inhibitor-treated EAE mice as well as EAE-induced mice. The enzyme activities of NADPH oxidase were inhibited by LeuSH. From these results, it can be considered that LeuSH acts as one of the antigen candidates in ameli...Continue Reading

References

Jun 1, 1992·Baillière's Clinical Rheumatology·J M Dayer, H Fenner
Jul 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·H E Van Wart, H Birkedal-Hansen
Jun 30, 1987·Biochemical and Biophysical Research Communications·T D Ocain, D H Rich
Jan 1, 1985·Molecular Aspects of Medicine·B Halliwell, J M Gutteridge
Jun 1, 1985·Archives of Biochemistry and Biophysics·D S PickeringW W Chan
Oct 1, 1995·Current Opinion in Cell Biology·H Birkedal-Hansen
Dec 15, 1995·Neuroscience Letters·S ChandlerE Bone
Jan 1, 1997·Free Radical Biology & Medicine·P BrenneisenK Scharffetter-Kochanek
Mar 1, 1997·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·E N Benveniste
Mar 14, 1998·Trends in Neurosciences·V W YongD R Edwards
Feb 1, 2000·Molecular Medicine Today·R GoldK V Toyka
May 5, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G A Upadhya, S M Strasberg
Feb 7, 2001·Journal of the National Cancer Institute·M Hidalgo, S G Eckhardt
Jan 5, 2002·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·R A Rudick
Aug 31, 2002·Glia·Gary A Rosenberg
Dec 4, 2003·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·W Brück, C Stadelmann
Mar 27, 2004·Physiological Reviews·Valeria S Ossovskaya, Nigel W Bunnett
Apr 28, 2005·Expert Review of Neurotherapeutics·Richard A Rudick, Alfred Sandrock
Aug 6, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Andrew WeaverV Wee Yong
Sep 13, 2005·Trends in Immunology·Lawrence Steinman, Scott S Zamvil
Sep 27, 2005·Current Neurovascular Research·Dusanka S Skundric
Jul 4, 2006·Free Radical Biology & Medicine·Jack van HorssenHelga E de Vries
Aug 26, 2006·Nature Clinical Practice. Neurology·Ruth Ann Marrie, Richard A Rudick
Mar 27, 2007·Journal of the Neurological Sciences·V Wee YongLuanne M Metz
Apr 21, 2007·Current Treatment Options in Neurology·Adrienne Boissy, Robert J Fox
Oct 9, 2007·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Robert A Bermel, Richard A Rudick
May 27, 2008·Journal of Autoimmunity·Valérie DardalhonAna C Anderson
May 12, 2010·Biochimie·Artur MuchaPaweł Kafarski

❮ Previous
Next ❯

Citations

Dec 24, 2013·Antioxidants & Redox Signaling·Malin HultqvistRikard Holmdahl
Jan 18, 2017·Molecular Neurodegeneration·Merry W MaDarrell W Brann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here